Terrier F, Schuknecht B, Fretz C, Vock P, Herschkowitz N
Institut für Diagnostiche Radiologie, Universität, Inselspital Bern.
Schweiz Med Wochenschr. 1990 Sep 1;120(35):1257-72.
The physical and biological background to magnetic resonance imaging (MRI) in patients with neoplasms is reviewed. The clinical indications for this method of diagnosis, staging, and follow-up of malignant neoplasms are discussed on the basis of the guidelines given by the MRI Consensus Conference on April 25-26, 1989, in Berne. MRI is the modality of choice in patients with neoplasms of the central nervous system and the musculoskeletal system. Further emerging indications for MRI are neoplasma of the ENT region, liver, and pelvic organs. Finally, the foreseeable developments in MRI and in magnetic resonance spectroscopy (MRS) are mentioned.
本文综述了肿瘤患者磁共振成像(MRI)的物理和生物学背景。基于1989年4月25 - 26日在伯尔尼举行的MRI共识会议给出的指南,讨论了这种用于恶性肿瘤诊断、分期和随访方法的临床适应症。MRI是中枢神经系统和肌肉骨骼系统肿瘤患者的首选检查方式。MRI进一步新出现的适应症是耳鼻喉区域、肝脏和盆腔器官的肿瘤。最后,还提到了MRI和磁共振波谱(MRS)可预见的发展。